MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients. (Q54571053)

1 June 2018

title

MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients. (English)

1 reference

1 June 2018

1 reference

Foote CJ

1

1 reference

1 June 2018

Greer W

2

1 reference

1 June 2018

Kiberd BA

3

1 reference

1 June 2018

Fraser A

4

1 reference

1 June 2018

Lawen J

5

1 reference

1 June 2018

Nashan B

6

1 reference

1 June 2018

Belitsky P

7

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 November 2006

1 reference

1 June 2018

Transplantation Proceedings

published in

1 reference

1 June 2018

volume

38

1 reference

1 June 2018

issue

9

1 reference

1 June 2018

page(s)

2847-2849

1 reference

1 June 2018

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Clinical aspects of the MDR1 (ABCB1) gene polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Identification of functionally variant MDR1 alleles among European Americans and African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.08.120

10.1016/J.TRANSPROCEED.2006.08.120

7 January 2021

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018